P-236 New polyclonal antibody therapeutic to treat esophageal adenocarcinoma and Barrett’s esophagus by targeting EPHB4

MLA

A. Scammell, et al. “P-236 New Polyclonal Antibody Therapeutic to Treat Esophageal Adenocarcinoma and Barrett’s Esophagus by Targeting EPHB4.” Annals of Oncology, vol. 31, July 2020, p. S167. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.04.318.

APA

A. Scammell, J. Zhang, David I. Watson, P. Garcia Valtanen, Michael Michael, John D. Hayball, Damian J. Hussey, & E. Parkinson-Lawrence. (2020). P-236 New polyclonal antibody therapeutic to treat esophageal adenocarcinoma and Barrett’s esophagus by targeting EPHB4. Annals of Oncology, 31, S167. https://doi.org/10.1016/j.annonc.2020.04.318

Chicago

A. Scammell, J. Zhang, David I. Watson, P. Garcia Valtanen, Michael Michael, John D. Hayball, Damian J. Hussey, and E. Parkinson-Lawrence. 2020. “P-236 New Polyclonal Antibody Therapeutic to Treat Esophageal Adenocarcinoma and Barrett’s Esophagus by Targeting EPHB4.” Annals of Oncology 31 (July): S167. doi:10.1016/j.annonc.2020.04.318.